Hollings Renton, President and CEO at ONYX PHARMACEUTICALS INC (ONXX), sold 153,400 shares at $28.17 ($4.3M) on 2007-02-21, disclosed to the SEC on 2007-02-23.
Open-market sale of $4.3M ONXX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.90 | 10,000 | $279K | 6.5% |
| 2 | $27.95 | 20,000 | $559K | 13.0% |
| 3 | $28.00 | 28,400 | $795K | 18.5% |
| 4 | $28.05 | 10,000 | $281K | 6.5% |
| 5 | $28.08 | 5,000 | $140K | 3.3% |
| 6 | $28.09 | 5,000 |
| $140K |
| 3.3% |
| 7 | $28.10 | 15,000 | $422K | 9.8% |
| 8 | $28.11 | 10,000 | $281K | 6.5% |
| 9 | $28.12 | 8,000 | $225K | 5.2% |
| 10 | $28.13 | 5,000 | $141K | 3.3% |
| 11 | $28.14 | 5,000 | $141K | 3.3% |
| 12 | $28.15 | 8,000 | $225K | 5.2% |
| 13 | $28.17 | 1,000 | $28K | 0.7% |
| 14 | $28.20 | 2,000 | $56K | 1.3% |
| 15 | $28.24 | 5,000 | $141K | 3.3% |
| 16 | $28.30 | 4,000 | $113K | 2.6% |
| 17 | $28.35 | 1,000 | $28K | 0.7% |
| 18 | $28.36 | 2,000 | $57K | 1.3% |
| 19 | $28.40 | 1,000 | $28K | 0.7% |
| 20 | $28.45 | 2,000 | $57K | 1.3% |
| 21 | $28.50 | 1,500 | $43K | 1.0% |
| 22 | $28.53 | 2,000 | $57K | 1.3% |
| 23 | $28.55 | 1,000 | $29K | 0.7% |
| 24 | $28.69 | 1,500 | $43K | 1.0% |
| Total | $28.09 avg | 153,400 | $4.3M | 100% |
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |